What is TestCard?
TestCard is an innovative at-home testing solution designed to deliver immediate, low-cost results. The company's core offering is a unique non-invasive urine test kit integrated into a postcard format. This is complemented by a mobile application that transforms a smartphone camera into a clinical-grade scanner, enabling users to analyze their test results efficiently and conveniently. TestCard aims to democratize health diagnostics by making them accessible and user-friendly.
How much funding has TestCard raised?
TestCard has raised a total of $11.7M across 2 funding rounds:
Angel/Seed
$1.7M
Unspecified
$10M
Angel/Seed (2018): $1.7M, investors not publicly disclosed
Unspecified (2022): $10M, investors not publicly disclosed
What's next for TestCard?
With the recent major strategic investment, TestCard is poised for significant expansion and further development of its at-home testing platform. The substantial capital raised suggests a focus on scaling operations, enhancing the mobile application's capabilities, and potentially broadening its diagnostic test offerings. This funding will likely accelerate TestCard's mission to provide accessible and immediate health insights to a wider consumer base, positioning it for increased market penetration in the rapidly evolving digital health and diagnostics industry.
See full TestCard company page
